I Pellicer

2.1k total citations · 1 hit paper
12 papers, 1.7k citations indexed

About

I Pellicer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I Pellicer has authored 12 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I Pellicer's work include Bladder and Urothelial Cancer Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Glycosylation and Glycoproteins Research (2 papers). I Pellicer is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Glycosylation and Glycoproteins Research (2 papers). I Pellicer collaborates with scholars based in Spain, United States and Argentina. I Pellicer's co-authors include Carlos Cordon‐Cardo, Donald Silver, Warren D.W. Heston, Zuo‐Feng Zhang, Irene Orlow, Louis Lacombe, Greg Hannon, Manuel Serrano, Victor E. Reuter and David Beach and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

I Pellicer

11 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate-specific membrane antigen expression in normal and malignant human tissues.

1997 1.3k citations Donald Silver, I Pellicer et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I Pellicer Spain	9	1.0k	754	518	492	199	12	1.7k
Lana S. Grauer United States	11	846 0.8×	599 0.8×	327 0.6×	443 0.9×	104 0.5×	15	1.5k
Ron Israeli United States	20	1.1k 1.0×	518 0.7×	592 1.1×	800 1.6×	296 1.5×	42	2.2k
Sai L. Su United States	18	681 0.7×	299 0.4×	534 1.0×	699 1.4×	121 0.6×	23	1.6k
Mary Lou Beckett United States	13	840 0.8×	600 0.8×	220 0.4×	299 0.6×	89 0.4×	18	1.2k
Anna Pacelli United States	26	2.1k 2.0×	717 1.0×	496 1.0×	589 1.2×	485 2.4×	47	2.9k
Sae Kim United States	8	795 0.8×	711 0.9×	321 0.6×	395 0.8×	42 0.2×	11	1.3k
Stephen D. Mikolajczyk United States	31	1.7k 1.7×	176 0.2×	600 1.2×	727 1.5×	215 1.1×	52	2.9k
W. D. W. Heston United States	8	482 0.5×	366 0.5×	199 0.4×	303 0.6×	63 0.3×	13	866
Kenneth S. Koeneman United States	21	948 0.9×	175 0.2×	503 1.0×	808 1.6×	351 1.8×	62	1.8k
Hiroshi Terasaki Japan	21	353 0.3×	244 0.3×	238 0.5×	287 0.6×	155 0.8×	46	1.4k

Countries citing papers authored by I Pellicer

Since Specialization

Citations

This map shows the geographic impact of I Pellicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Pellicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Pellicer more than expected).

Fields of papers citing papers by I Pellicer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Pellicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Pellicer. The network helps show where I Pellicer may publish in the future.

Co-authorship network of co-authors of I Pellicer

This figure shows the co-authorship network connecting the top 25 collaborators of I Pellicer. A scholar is included among the top collaborators of I Pellicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Pellicer. I Pellicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Flores, Isabel, et al.. (2025). Route of Surgery for Sentinel Node Biopsy in Endometrial Cancer: Laparoscopy Versus Robotics. Journal of Clinical Medicine. 14(12). 4013–4013.

2.

Roca, Xavier, José Luís Mate, Aurelio Ariza, et al.. (1998). CD44 Isoform Expression Follows Two Alternative Splicing Pathways in Breast Tissue. American Journal Of Pathology. 153(1). 183–190. 20 indexed citations

3.

Orlow, Irene, Louis Lacombe, I Pellicer, et al.. (1998). Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. International Journal of Cancer. 75(6). 819–824. 3 indexed citations

4.

Castellà, E., et al.. (1998). Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.. Journal of Clinical Pathology. 51(2). 134–137. 25 indexed citations

5.

Orlow, Irene, Louis Lacombe, I Pellicer, et al.. (1998). Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. International Journal of Cancer. 75(6). 819–824. 31 indexed citations

6.

Osman, Iman, Howard I. Scher, Zuo‐Feng Zhang, et al.. (1997). Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.. PubMed. 3(4). 531–6. 28 indexed citations

7.

Silver, Donald, et al.. (1997). Prostate-specific membrane antigen expression in normal and malignant human tissues.. PubMed. 3(1). 81–5. 1295 indexed citations breakdown →

8.

Carles, Joan, Adolfo J. Ariza, R. Rosell, et al.. (1996). Prognostic implications of P-glycoprotein, epidermal growth factor receptor and transforming growth factor alpha. Oncology Reports. 3(4). 781–785. 1 indexed citations

9.

Orlow, Irene, Louis Lacombe, Greg Hannon, et al.. (1995). Deletion of the p16 and p15 Genes in Human Bladder Tumors. JNCI Journal of the National Cancer Institute. 87(20). 1524–1529. 147 indexed citations

10.

Chin, Lih‐Shen, Nicole Schreiber‐Agus, I Pellicer, et al.. (1995). Contrasting roles for Myc and Mad proteins in cellular growth and differentiation.. Proceedings of the National Academy of Sciences. 92(18). 8488–8492. 82 indexed citations

11.

Carles, Joan, Rafael Rosell, Adolfo J. Ariza, et al.. (1993). Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer. 10(3-4). 209–219. 59 indexed citations

12.

Rosell, Rafael, Joan Carles, Nuria Ribelles, et al.. (1991). A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer. Cancer. 67(10). 2448–2453. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact